The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin and prednisone for previously untreated diffuse large B-cell lymphoma: A real-world, multi-center, retrospective cohort study.
 
Peiqi Zhao
No Relationships to Disclose
 
Shu Zhao
No Relationships to Disclose
 
Chen Huang
No Relationships to Disclose
 
Jiesong Wang
No Relationships to Disclose
 
Junqing Xu
No Relationships to Disclose
 
Yajun Li
No Relationships to Disclose
 
Ningning Zhang
No Relationships to Disclose
 
Hui Zhou
No Relationships to Disclose
 
Yuhuan Gao
No Relationships to Disclose
 
Qingyuan Zhang
No Relationships to Disclose
 
Huilai Zhang
No Relationships to Disclose